Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action- |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Discovery | - | 06 Jan 2022 | |
Neoplasms | Discovery | - | 06 Jan 2022 |